PET-based Evaluation of Chemotherapy-induced Brain Damage in Lymphoma
NCT02601547
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Lymphoma
Interventions
DEVICE:
PET-FDG brain imaging and NPT
Sponsor
University Hospital, Toulouse